Terms: = Endocrine gland cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
334 results:
1. Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group.
Weiss L; Fischer LE; Heinemann V; Gieseler F; Hoehler T; Mayerle J; Quietzsch D; Reinacher-Schick A; Schenk M; Seipelt G; Siveke JT; Stahl M; Kaiser U; Waldschmidt DT; Dorman K; Zhang D; Westphalen CB; Boeck S; Haas M
ESMO Open; 2024 Apr; 9(4):102944. PubMed ID: 38503144
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma.
Shinojima N; Yano S; Uchida D; Mizukami N; Mabe H; Kawashima J; Igata M; Kondo T; Uetani H; Yamamoto T; Uekawa K; Hide T; Mikami Y; Hirai T; Mukasa A
J Clin Neurosci; 2024 Feb; 120():138-146. PubMed ID: 38244528
[TBL] [Abstract] [Full Text] [Related]
3. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
Yang Y; Yue C; Li Y; Piao Y
Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
[TBL] [Abstract] [Full Text] [Related]
4. Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma.
Harada T; Uemura K; Sumiyoshi T; Shintakuya R; Okada K; Hara T; Takahashi S; Hiyama E
Pancreatology; 2023 Dec; 23(8):996-1002. PubMed ID: 37945497
[TBL] [Abstract] [Full Text] [Related]
5. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
[TBL] [Abstract] [Full Text] [Related]
6. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Preoperative Tumor Size on prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas.
Miyata Y; Yonamine N; Fujinuma I; Tsunenari T; Takihata Y; Hakoda H; Nakazawa A; Iwasaki T; Einama T; Togashi J; Tsujimoto H; Ueno H; Beck Y; Kishi Y
Ann Surg Oncol; 2023 Dec; 30(13):8621-8630. PubMed ID: 37658273
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas.
Oz O; Argon A; Kebat TA; Ozdemir O; Yakan S
Indian J Pathol Microbiol; 2023; 66(3):533-539. PubMed ID: 37530334
[TBL] [Abstract] [Full Text] [Related]
9. Predictive value of systemic inflammatory markers for recurrence of papillary thyroid cancer.
Wang G; Ma Y; Liu Y; Fan Y; Miao X; Zhang Y; Zhu H
J Surg Oncol; 2023 Oct; 128(5):743-748. PubMed ID: 37243870
[TBL] [Abstract] [Full Text] [Related]
10. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.
Polen-De C; Giri S; Fadadu P; Weaver A; Mcgree ME; Moynagh M; Takahashi N; Jatoi A; Lebrasseur NK; Cliby W; Williams G; Kumar A
J Natl Cancer Inst Monogr; 2023 May; 2023(61):43-48. PubMed ID: 37139982
[TBL] [Abstract] [Full Text] [Related]
11. Differentiated thyroid cancer: Case report of false positive
Giannoula E; Koutsouki G; Exadaktylou P; Papadopoulos N; Papanastasiou E; Doumas A; Iakovou I
Hell J Nucl Med; 2023; 26(1):66-69. PubMed ID: 37031423
[TBL] [Abstract] [Full Text] [Related]
12. Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
Patti L; Gay S; Musso L; Maltese C; Spina B; Minuto M; Morbelli S; Vera L; Boschetti M; Ferone D; Albertelli M
J Endocrinol Invest; 2023 Oct; 46(10):2157-2164. PubMed ID: 36976482
[TBL] [Abstract] [Full Text] [Related]
13. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer.
Kawahara N; Kawaguchi R; Waki K; Maehana T; Yamanaka S; Yamada Y; Kimura F
Sci Rep; 2022 Dec; 12(1):22636. PubMed ID: 36587139
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical characteristics and prognosis in papillary thyroid carcinoma patients with recurrent laryngeal nerve invasion].
Chen JM; Fang JG; Zhong Q; Hou LZ; Ma HZ; Feng L; He SZ; Shi Q; Lian M; Wang R; Shen XX
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3868-3874. PubMed ID: 36540925
[No Abstract] [Full Text] [Related]
15. Clinicopathological Characteristics and prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.
Wu B; Li J; Tao X; Wang J; Zhu G; Lu X; Chen R
Reprod Sci; 2023 Jun; 30(6):1927-1937. PubMed ID: 36512190
[TBL] [Abstract] [Full Text] [Related]
16. The Clinicopathologic Characteristics and Outcomes of Gastroentero-pancreatic Neuroendocrine Tumors - Experience from A Tertiary cancer Center.
Ali J; Rahat A; Shah MH; Sajjad M; Malik I; Ikram SI; Ul Qamar MF
Gulf J Oncolog; 2022 Sep; 1(40):7-14. PubMed ID: 36448065
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract] [Full Text] [Related]
18. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
19. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.
Casadei R; Ricci C; Ingaldi C; Alberici L; De Raffele E; Barcia B; Mosconi C; Diegoli M; Di Marco M; Brandi G; Zagari RM; Pagano N; Eusebi LH; Serra C; Migliori M; Guido A; Santini D; Rosini F; Malvi D; Minni F
Updates Surg; 2022 Oct; 74(5):1533-1542. PubMed ID: 36008632
[TBL] [Abstract] [Full Text] [Related]
20. I-PET score: Combining whole body iodine and
Wijewardene A; Hoang J; Maw AM; Gild M; Tacon L; Roach P; Schembri G; Chan D; Clifton-Bligh R
Clin Endocrinol (Oxf); 2023 Mar; 98(3):436-446. PubMed ID: 35918798
[TBL] [Abstract] [Full Text] [Related]
[Next]
